ICON Reports Q3 Revenue Growth of 7% to $241 Million and Net New Business of $431 Million

DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2011.